Virtual Acumen Release: Nanoscience Breakthrough For Drug Discovery And Drug Delivery

SAN DIEGO, Jan. 12 /PRNewswire/ -- Dr. Cedric Loiret-Bernal, President and CEO of NanoInk, Inc., will be interviewed on BioTech Today at 1 p.m. PST, on Wednesday, January 14th, at http://www.biotechtoday.net/ . NanoInk, Inc. is a Chicago-based company commercializing the Dip Pen Nanolithography (DPN) method of nanoscale manufacturing. DPN is a patented process used to build nanometer-scale structures and patterns by literally drawing materials directly onto a surface.

"NanoInk's patented process will revolutionize fields as diverse as life sciences and computer chip fabrication. This isn't a 'sometime maybe' piece of technology -- this is the latest move forward in applied physics at the nanoscale level," says Sam Kephart, Executive Producer of BioTech Today.

BioTech Today is a weekly talk radio show, streamed live via the web, focusing on biotechnology, nanotechnology, pharma, and biomedicine. Its mission is to create an industry forum to promote the success of the biotechnology and nanotechnology industries. The promise of biotech and nanotech impacts directly on our well-being, now and in the future, and is of vastly greater significance than the daily stock price fluctuations or even quarterly financial reports of the companies involved. By providing a supportive conversational environment for entrepreneurs, CEOs, researchers, venture capitalists, and intellectual property attorneys, BioTech Today participates in the process of strengthening the biotech and nanotech sectors, with beneficial effects on the industries, their sources of financial support, and the public at large.

BioTech Today is co-hosted by Dr. David Lemberg and Sam Kephart, who bring their combined skill set of biotech smarts and business savvy to the studio microphone.

Dr. David Lemberg (619-540-9038; davidlemberg@earthlink.net ) is a biotechnology communications consultant with a formal background in biochemistry research.

Sam Kephart (619-889-8558; sam2sam@aol.com ) is President and CEO of Virtual Acumen, a digital media developer, specializing in medical e-learning, based in San Diego.

CONTACT: Dr. David Lemberg of BioTech Today, +1-619-540-9038, or fax,+1-858-793-0366, davidlemberg@earthlink.net

Web site: http://www.biotechtoday.net/